ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
6.13
-0.19 (-3.01%)
At close: Oct 21, 2025, 4:00 PM EDT
6.01
-0.12 (-1.96%)
Pre-market: Oct 22, 2025, 6:36 AM EDT
ENDRA Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$38.00
Upside
+519.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +519.90% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +650.41% | May 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $75 → $50 | Strong Buy | Maintains | $75 → $50 | +715.66% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +228,284.99% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $175,000 → $15,750 | Strong Buy | Reiterates | $175,000 → $15,750 | +256,833.12% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $210,000 → $175,000 | Strong Buy | Maintains | $210,000 → $175,000 | +2,854,712.40% | Apr 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $210,000 | Strong Buy | Initiates | $210,000 | +3,425,674.88% | Jul 15, 2019 |